Safety and Efficacy of Exenatide as Monotherapy

NCT00381342 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

233

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: exenatide
DRUG: exenatide
DRUG: placebo

Sponsor

AstraZeneca

Collaborators

[object Object]